Natixis Investment Managers International Abiomed Inc Transaction History

Natixis Investment Managers International

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$281.08 - $444.25 $1.17 Million - $1.84 Million	-4,151 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$354.53 - $449.75 $1.47 Million - $1.87 Million	4,151 New	4,151 $1.87 Million
Q4 2017 Feb 14, 2018	SELL	$168.78 - $199.74 $110,719 - $131,029	-656 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$145.39 - $168.6 $95,375 - $110,601	656	656 $111,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

Stay updated on Natixis Investment Managers International with notifications on news.